Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-09-25 AGM Information
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceeding of the 60th Annual General Meeting' and details the conduct of the AGM held on 25th September 2023. It includes information about the meeting's attendees, the agenda items discussed, resolutions passed, and voting procedures. It does not contain the full annual report or financial statements themselves but rather a summary of the meeting proceedings. The document also mentions that voting results will be disclosed separately. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including meeting proceedings. The document length (6969 characters) is consistent with a detailed AGM proceeding note rather than a brief announcement or a full annual report. Therefore, the correct classification is AGM-R with high confidence.
2023-09-25 English
Proceeding of the 60th Annual General Meeting of Unichem Laboratories Ltd.
AGM Information Classification · 95% confidence The document is titled 'Proceeding of the 60th Annual General Meeting' and details the conduct of the AGM held on 25th September 2023. It includes information about the meeting's attendees, the agenda items discussed, resolutions passed, and voting procedures. It specifically mentions the adoption of audited financial statements and reports but does not contain the financial statements themselves or detailed financial data. The document is a record of the AGM proceedings rather than the full Annual Report or financial statements. It also references that voting results will be disclosed separately. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including meeting proceedings. The document length (6969 characters) supports it being a detailed meeting proceeding rather than a brief announcement or a full report. Therefore, the correct classification is AGM Information (AGM-R).
2023-09-25 English
Open Offer
Regulatory Filings
2023-09-25 English
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement for the attention of the Equity Shareholders of Unichem Laboratories Ltd ("Target ....
Regulatory Filings
2023-09-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd
Regulatory Filings
2023-09-21 English
Updates
Major Shareholding Notification Classification · 100% confidence The document is an intimation under Regulation 30 of SEBI LODR Regulations regarding the acquisition of shares by Ipca Laboratories Limited in Unichem Laboratories Limited. It details the acquisition of shares through an open offer, the resulting change in shareholding percentage, and the fact that Unichem Laboratories has become a subsidiary of Ipca Laboratories. The document is an announcement of a change in major shareholding and control, not a financial report or earnings release. It does not contain financial statements or detailed financial data. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length is 3596 characters, which is consistent with an announcement rather than a full report.
2023-09-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.